spacer
home > pmps > autumn 2018 > managing medication
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Managing Medication

Medication nonadherence is a serious public health issue. It costs the NHS approximately £500 million every year, as well as countless hours of work dealing with problems which arise due to patients not taking prescribed medications as directed. As the former US general surgeon, Dr C Everett Koop, stated, “drugs don’t work in patients who don’t take them.”

Across the UK, one billion items are prescribed and dispensed by pharmacists every year. However, one in five patients surveyed as part of the True Cost of Medication Non- Adherence report admitted to not taking their medication as prescribed. “Non-adherence is a big problem,” Ric Fordham, Professor of Applied Health and Economics at the University of East Anglia, UK, said in the study. “When patients don’t feel ill, or they start to feel better, they think there is no need for them to take their drugs anymore. Patients then don’t get the full benefit of them and that ends up reducing the cost effectiveness of the drugs.”

Nonadherence can be classified as intentional (when a patient actively decides not to take medication or follow treatment recommendations) or unintentional (which can be caused by misunderstanding the prescription requirements, an inability to access or administer prescribed medication, or simple forgetfulness). The National Institute for Health and Care Excellence states that nonadherence should not be considered as just the patient’s problem; ultimately, it represents a fundamental limitation in the delivery of healthcare.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Oliver Pittock is the Managing Director of pharmaceutical packaging specialist, Valley Northern. Oliver built his commitment to the healthcare and pharmacy supply business through seeing his father’s business grow throughout the 1970s. Moving to the Midlands in 1993, Oliver set up Valley Northern, which became a limited company in 2014.
spacer
Oliver Pittock
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Destiny Pharma appoints MedPharm to develop new XF-platform drug formulations

Destiny Pharma, a clinical stage biotechnology company focused on the development of novel antimicrobial drugs, is pleased to announce that it has appointed MedPharm as its expert partner to develop new topical formulations of the Company’s novel XF-platform compounds. These new treatments for dermal and ocular infections are part of its second clinical programme to address the global problem of anti-microbial resistance (AMR). MedPharm is a world leading contract provider of topical and transdermal product design and formulation development services using sophisticated in vitro models to de-risk development programmes.
More info >>

White Papers

Clinical Trials in Ukraine: Orange Paper Overview and 1st Half Year 2014

Synergy Research Group

The Orange Paper is an analytical report about the clinical trials market in Russia, published quarterly by the contract research organization Synergy Research Group. The first edition of Orange Paper was released in 2006, and at the moment 31 issues have already published. Now, thanks to Synergy Group Ukraine, obtaining information about the market of clinical trials in Ukraine has become possible. In Ukraine, during the period from 1996 to 2013, applicants had obtained 3,864 positive conclusions about the possibility of conducting clinical trials of drugs, both for domestic and foreign manufacturers, including conduct of multinational multi-center clinical trials (hereinafter – MMCTs)
More info >>

 
Industry Events

CPhI & P-MEC China

18-20 June 2019, SNIEC, Shanghai, China

CPhI & P-MEC China 2019 is your gateway to successfully grow your business at the 2nd largest pharma market in the world. Whether you are looking for sourcing new business or getting the latest market insight, this is your one-stop shop pharmaceutical platform in Asia.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement